Intrauterine Devices Market
Intrauterine Devices Market Forecasts to 2030 - Global Analysis By Type (Hormonal IUDs, Non-Hormonal IUDs and Other Types), Material, Age Group, End User and By Geography
According to Stratistics MRC, the Global Intrauterine Devices Market is accounted for $6.6 billion in 2024 and is expected to reach $9.15 billion by 2030 growing at a CAGR of 5.6% during the forecast period. Intrauterine devices (IUDs) are small, T-shaped medical devices inserted into the uterus to provide long-term, reversible contraception. They work by preventing sperm from fertilizing an egg or altering the uterine lining to prevent implantation. IUDs are highly effective, with hormonal and non-hormonal options available. Hormonal IUDs release progestin, while copper IUDs use copper to create a toxic environment for sperm. IUDs are a popular choice due to their convenience, cost-effectiveness, and long duration of action, lasting up to 5-10 years.
According to data by Family Planning NSW, hormonal IUDs are found to have an edge over copper intrauterine devices in terms of efficiency where they provide 99.8% efficiency over copper IUDs, which provide 99.2% efficiency.
Market Dynamics:
Driver:
Rising awareness of family planning
The demand for effective and long-lasting contraception like IUDs is increasing due to increased awareness among women about reproductive health options. This is fuelled by government campaigns, healthcare programs, and community outreach, as well as increased accessibility of information through media and social platforms. Additionally, changing societal attitudes towards family planning and women's reproductive rights have encouraged open conversations about contraception. As a result, more women are choosing IUDs as a reliable and convenient method of birth control, contributing to the IUD market expansion.
Restraint:
Lack of awareness and misconceptions
Lack of awareness and misconceptions, especially in developing regions, are not fully informed about the safety and efficacy of IUDs, leading to hesitations in choosing this method of contraception. Misunderstandings regarding potential side effects, such as pain, discomfort, or infertility, further discourage usage. Cultural and societal taboos around birth control also prevent women from seeking IUDs as an option. As a result, despite their effectiveness and long-term benefits, IUDs remain underutilized in certain markets, especially where educational resources are limited or there is a lack of healthcare provider support.
Opportunity:
Telemedicine and remote consultations
The use of virtual consultations and IUD insertions has revolutionized the reproductive health industry by breaking down geographical barriers, providing convenient access to expert consultations, reducing anxiety, improving education, and facilitating efficient follow-up appointments. In addition, it reduces healthcare expenses, offers prompt access, and permits individualised counselling regarding the advantages and disadvantages of IUDs. Virtual consultations provide a comfortable and private setting for discussing sensitive topics, while IUD insertions ensure optimal efficacy and safety. This has led to increased awareness, uptake, and satisfaction with IUDs, ultimately driving market growth.
Threat:
Adverse publicity and safety concerns
Adverse publicity and safety concerns, such as perforation, infection, or expulsion of the device, can create fear among potential users. Safety concerns about side effects, including irregular bleeding, hormonal imbalances, or pain during insertion, may deter women from choosing IUDs. Additionally, misinformation and anecdotal reports can amplify fear, especially in regions with limited awareness and education. Adverse publicity from previous lawsuits or recalls regarding certain IUD brands may erode trust in the product. These factors lead to reduced demand and hesitation among healthcare providers to recommend IUDs, limiting market growth.
Covid-19 Impact
The COVID-19 pandemic negatively impacted the intrauterine device (IUD) market, primarily due to reduced access to healthcare services as lockdowns and restrictions limited elective procedures. Many patients faced delays or cancellations in appointments, disrupting IUD insertions and replacements. Supply chain disruptions also hindered product availability. However, as restrictions eased, demand rebounded due to the resumption of reproductive health services and a renewed focus on long-term contraception options.
The hormonal IUDs segment is expected to be the largest during the forecast period
During the forecast period, the hormonal IUDs segment is anticipated to register as the largest market share, due to their enhanced benefits over non-hormonal options. Hormonal IUDs, such as Mirena, provide long-term contraception while also offering additional health benefits like reduced menstrual bleeding and management of conditions like endometriosis. Their ability to release hormones gradually, such as levonorgestrel, makes them popular among women seeking reliable, low-maintenance contraception. The segment is expanding with growing awareness and rising preference for hormonal IUDs in regions with improving healthcare access.
The hospitals segment is expected to have the highest CAGR during the forecast period
During the projection period, the hospitals segment is expected to grow at the highest CAGR, by providing a trusted healthcare setting for insertion and consultation. Hospitals offer a comprehensive range of reproductive health services, making them a primary point of access for women seeking long-term contraception. Additionally, hospitals provide the necessary infrastructure and skilled professionals for proper IUD insertion, reducing the risk of complications. Increased awareness, government programs, and expanding healthcare services within hospitals are driving the adoption of IUDs. Hospitals also serve as platforms for educating women on the benefits of IUDs, contributing to market growth.
Region with largest share:
During the estimation period, the Asia Pacific region is expected to capture the largest market share due to improved healthcare infrastructure. Countries like India and China are witnessing higher adoption rates as family planning programs and government initiatives promote IUD use. Despite cultural barriers and misconceptions, the availability of both hormonal and copper IUDs is helping drive market expansion. Additionally, rising disposable incomes, access to healthcare, and increasing awareness about reproductive health are propelling demand across this region.
Region with highest CAGR:
The North America region is projected to achieve the highest CAGR during the forecast period, owing to supportive healthcare policies. The U.S. and Canada have seen a rise in demand for IUDs as an effective, low-maintenance birth control method, driven by a focus on women’s health. Government initiatives and health insurance coverage for reproductive health services have also boosted market growth. Additionally, technological advancements in IUD designs, including hormone-releasing options, contribute to their popularity. However, misconceptions and side effect concerns remain challenges to wider adoption.
Key players in the market
Some of the key players profiled in the Intrauterine Devices Market include Bayer AG, Teva Pharmaceutical Industries Ltd., Allergan plc, CooperSurgical Inc., DKT International, HLL Lifecare Limited, SMB Corporation of India, Pregna International Limited, Meril Life Sciences Pvt. Ltd., Medisafe Distribution Inc., China RH Contraceptives Co., Ltd., Mona Lisa N.V., Prosan International B.V., Ocon Medical Ltd., Egemen International, Besins HealthCare, Shenyang Liren Gynecology Health Technology Co., Ltd., Cupid Limited, Bersil Contraceptives Pvt. Ltd. and Sanghai Dahua Medical Apparatus Co., Ltd.
Key Developments:
In August 2024, Teva and Alvotech received FDA approval for an additional presentation of SELARSDI® (ustekinumab), a biosimilar to Stelara®. This partnership leverages Alvotech’s expertise in biosimilars and Teva’s commercialization capabilities to expand the treatment options for autoimmune disorders in the U.S. market.
In August 2024, CooperSurgical acquired obp Surgical, a company specializing in single-use surgical devices with integrated lighting. This acquisition, valued at approximately $100 million, enhances CooperSurgical's range of devices, particularly through the ONETRAC™ surgical retractors and suction devices, designed to improve clinical efficiency in various surgical procedures.
In July 2024, Teva announced collaboration with Launch Therapeutics to accelerate the clinical development of an innovative asthma inhaler combining an inhaled corticosteroid with a short-acting beta-agonist (ICS-SABA), aiming to improve outcomes for asthma patients. This project is part of Teva's commitment to advancing respiratory therapies.
Types Covered:
• Hormonal IUDs
• Non-Hormonal IUDs
• Other Types
Materials Covered:
• Hormonal (Levonorgestrel)
• Copper
• Other Materials
Age Groups Covered:
• Teenagers
• Adult Women
• Other Age Groups
End Users Covered:
• Hospitals
• Gynaecology Clinics
• Community Healthcare Centers
• Home Care Settings
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Intrauterine Devices Market, By Type
5.1 Introduction
5.2 Hormonal IUDs
5.3 Non-Hormonal IUDs
5.4 Other Types
6 Global Intrauterine Devices Market, By Material
6.1 Introduction
6.2 Levonorgestrel
6.3 Copper
6.4 Other Materials
7 Global Intrauterine Devices Market, By Age Group
7.1 Introduction
7.2 Teenagers
7.3 Adult Women
7.4 Other Age Groups
8 Global Intrauterine Devices Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Gynecology Clinics
8.4 Community Healthcare Centers
8.5 Home Care Settings
8.6 Other End Users
9 Global Intrauterine Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Bayer AG
11.2 Teva Pharmaceutical Industries Ltd.
11.3 Allergan plc
11.4 CooperSurgical Inc.
11.5 DKT International
11.6 HLL Lifecare Limited
11.7 SMB Corporation of India
11.8 Pregna International Limited
11.9 Meril Life Sciences Pvt. Ltd.
11.10 Medisafe Distribution Inc.
11.11 China RH Contraceptives Co., Ltd.
11.12 Mona Lisa N.V.
11.13 Prosan International B.V.
11.14 Ocon Medical Ltd.
11.15 Egemen International
11.16 Besins HealthCare
11.17 Shenyang Liren Gynecology Health Technology Co., Ltd.
11.18 Cupid Limited
11.19 Bersil Contraceptives Pvt. Ltd.
11.20 Sanghai Dahua Medical Apparatus Co., Ltd.
List of Tables
1 Global Intrauterine Devices Market Outlook, By Region (2022-2030) ($MN)
2 Global Intrauterine Devices Market Outlook, By Type (2022-2030) ($MN)
3 Global Intrauterine Devices Market Outlook, By Hormonal IUDs (2022-2030) ($MN)
4 Global Intrauterine Devices Market Outlook, By Non-Hormonal IUDs (2022-2030) ($MN)
5 Global Intrauterine Devices Market Outlook, By Other Types (2022-2030) ($MN)
6 Global Intrauterine Devices Market Outlook, By Material (2022-2030) ($MN)
7 Global Intrauterine Devices Market Outlook, By Levonorgestrel (2022-2030) ($MN)
8 Global Intrauterine Devices Market Outlook, By Copper (2022-2030) ($MN)
9 Global Intrauterine Devices Market Outlook, By Other Materials (2022-2030) ($MN)
10 Global Intrauterine Devices Market Outlook, By Age Group (2022-2030) ($MN)
11 Global Intrauterine Devices Market Outlook, By Teenagers (2022-2030) ($MN)
12 Global Intrauterine Devices Market Outlook, By Adult Women (2022-2030) ($MN)
13 Global Intrauterine Devices Market Outlook, By Other Age Groups (2022-2030) ($MN)
14 Global Intrauterine Devices Market Outlook, By End User (2022-2030) ($MN)
15 Global Intrauterine Devices Market Outlook, By Hospitals (2022-2030) ($MN)
16 Global Intrauterine Devices Market Outlook, By Gynecology Clinics (2022-2030) ($MN)
17 Global Intrauterine Devices Market Outlook, By Community Healthcare Centers (2022-2030) ($MN)
18 Global Intrauterine Devices Market Outlook, By Home Care Settings (2022-2030) ($MN)
19 Global Intrauterine Devices Market Outlook, By Other End Users (2022-2030) ($MN)
20 North America Intrauterine Devices Market Outlook, By Country (2022-2030) ($MN)
21 North America Intrauterine Devices Market Outlook, By Type (2022-2030) ($MN)
22 North America Intrauterine Devices Market Outlook, By Hormonal IUDs (2022-2030) ($MN)
23 North America Intrauterine Devices Market Outlook, By Non-Hormonal IUDs (2022-2030) ($MN)
24 North America Intrauterine Devices Market Outlook, By Other Types (2022-2030) ($MN)
25 North America Intrauterine Devices Market Outlook, By Material (2022-2030) ($MN)
26 North America Intrauterine Devices Market Outlook, By Levonorgestrel (2022-2030) ($MN)
27 North America Intrauterine Devices Market Outlook, By Copper (2022-2030) ($MN)
28 North America Intrauterine Devices Market Outlook, By Other Materials (2022-2030) ($MN)
29 North America Intrauterine Devices Market Outlook, By Age Group (2022-2030) ($MN)
30 North America Intrauterine Devices Market Outlook, By Teenagers (2022-2030) ($MN)
31 North America Intrauterine Devices Market Outlook, By Adult Women (2022-2030) ($MN)
32 North America Intrauterine Devices Market Outlook, By Other Age Groups (2022-2030) ($MN)
33 North America Intrauterine Devices Market Outlook, By End User (2022-2030) ($MN)
34 North America Intrauterine Devices Market Outlook, By Hospitals (2022-2030) ($MN)
35 North America Intrauterine Devices Market Outlook, By Gynecology Clinics (2022-2030) ($MN)
36 North America Intrauterine Devices Market Outlook, By Community Healthcare Centers (2022-2030) ($MN)
37 North America Intrauterine Devices Market Outlook, By Home Care Settings (2022-2030) ($MN)
38 North America Intrauterine Devices Market Outlook, By Other End Users (2022-2030) ($MN)
39 Europe Intrauterine Devices Market Outlook, By Country (2022-2030) ($MN)
40 Europe Intrauterine Devices Market Outlook, By Type (2022-2030) ($MN)
41 Europe Intrauterine Devices Market Outlook, By Hormonal IUDs (2022-2030) ($MN)
42 Europe Intrauterine Devices Market Outlook, By Non-Hormonal IUDs (2022-2030) ($MN)
43 Europe Intrauterine Devices Market Outlook, By Other Types (2022-2030) ($MN)
44 Europe Intrauterine Devices Market Outlook, By Material (2022-2030) ($MN)
45 Europe Intrauterine Devices Market Outlook, By Levonorgestrel (2022-2030) ($MN)
46 Europe Intrauterine Devices Market Outlook, By Copper (2022-2030) ($MN)
47 Europe Intrauterine Devices Market Outlook, By Other Materials (2022-2030) ($MN)
48 Europe Intrauterine Devices Market Outlook, By Age Group (2022-2030) ($MN)
49 Europe Intrauterine Devices Market Outlook, By Teenagers (2022-2030) ($MN)
50 Europe Intrauterine Devices Market Outlook, By Adult Women (2022-2030) ($MN)
51 Europe Intrauterine Devices Market Outlook, By Other Age Groups (2022-2030) ($MN)
52 Europe Intrauterine Devices Market Outlook, By End User (2022-2030) ($MN)
53 Europe Intrauterine Devices Market Outlook, By Hospitals (2022-2030) ($MN)
54 Europe Intrauterine Devices Market Outlook, By Gynecology Clinics (2022-2030) ($MN)
55 Europe Intrauterine Devices Market Outlook, By Community Healthcare Centers (2022-2030) ($MN)
56 Europe Intrauterine Devices Market Outlook, By Home Care Settings (2022-2030) ($MN)
57 Europe Intrauterine Devices Market Outlook, By Other End Users (2022-2030) ($MN)
58 Asia Pacific Intrauterine Devices Market Outlook, By Country (2022-2030) ($MN)
59 Asia Pacific Intrauterine Devices Market Outlook, By Type (2022-2030) ($MN)
60 Asia Pacific Intrauterine Devices Market Outlook, By Hormonal IUDs (2022-2030) ($MN)
61 Asia Pacific Intrauterine Devices Market Outlook, By Non-Hormonal IUDs (2022-2030) ($MN)
62 Asia Pacific Intrauterine Devices Market Outlook, By Other Types (2022-2030) ($MN)
63 Asia Pacific Intrauterine Devices Market Outlook, By Material (2022-2030) ($MN)
64 Asia Pacific Intrauterine Devices Market Outlook, By Levonorgestrel (2022-2030) ($MN)
65 Asia Pacific Intrauterine Devices Market Outlook, By Copper (2022-2030) ($MN)
66 Asia Pacific Intrauterine Devices Market Outlook, By Other Materials (2022-2030) ($MN)
67 Asia Pacific Intrauterine Devices Market Outlook, By Age Group (2022-2030) ($MN)
68 Asia Pacific Intrauterine Devices Market Outlook, By Teenagers (2022-2030) ($MN)
69 Asia Pacific Intrauterine Devices Market Outlook, By Adult Women (2022-2030) ($MN)
70 Asia Pacific Intrauterine Devices Market Outlook, By Other Age Groups (2022-2030) ($MN)
71 Asia Pacific Intrauterine Devices Market Outlook, By End User (2022-2030) ($MN)
72 Asia Pacific Intrauterine Devices Market Outlook, By Hospitals (2022-2030) ($MN)
73 Asia Pacific Intrauterine Devices Market Outlook, By Gynecology Clinics (2022-2030) ($MN)
74 Asia Pacific Intrauterine Devices Market Outlook, By Community Healthcare Centers (2022-2030) ($MN)
75 Asia Pacific Intrauterine Devices Market Outlook, By Home Care Settings (2022-2030) ($MN)
76 Asia Pacific Intrauterine Devices Market Outlook, By Other End Users (2022-2030) ($MN)
77 South America Intrauterine Devices Market Outlook, By Country (2022-2030) ($MN)
78 South America Intrauterine Devices Market Outlook, By Type (2022-2030) ($MN)
79 South America Intrauterine Devices Market Outlook, By Hormonal IUDs (2022-2030) ($MN)
80 South America Intrauterine Devices Market Outlook, By Non-Hormonal IUDs (2022-2030) ($MN)
81 South America Intrauterine Devices Market Outlook, By Other Types (2022-2030) ($MN)
82 South America Intrauterine Devices Market Outlook, By Material (2022-2030) ($MN)
83 South America Intrauterine Devices Market Outlook, By Levonorgestrel (2022-2030) ($MN)
84 South America Intrauterine Devices Market Outlook, By Copper (2022-2030) ($MN)
85 South America Intrauterine Devices Market Outlook, By Other Materials (2022-2030) ($MN)
86 South America Intrauterine Devices Market Outlook, By Age Group (2022-2030) ($MN)
87 South America Intrauterine Devices Market Outlook, By Teenagers (2022-2030) ($MN)
88 South America Intrauterine Devices Market Outlook, By Adult Women (2022-2030) ($MN)
89 South America Intrauterine Devices Market Outlook, By Other Age Groups (2022-2030) ($MN)
90 South America Intrauterine Devices Market Outlook, By End User (2022-2030) ($MN)
91 South America Intrauterine Devices Market Outlook, By Hospitals (2022-2030) ($MN)
92 South America Intrauterine Devices Market Outlook, By Gynecology Clinics (2022-2030) ($MN)
93 South America Intrauterine Devices Market Outlook, By Community Healthcare Centers (2022-2030) ($MN)
94 South America Intrauterine Devices Market Outlook, By Home Care Settings (2022-2030) ($MN)
95 South America Intrauterine Devices Market Outlook, By Other End Users (2022-2030) ($MN)
96 Middle East & Africa Intrauterine Devices Market Outlook, By Country (2022-2030) ($MN)
97 Middle East & Africa Intrauterine Devices Market Outlook, By Type (2022-2030) ($MN)
98 Middle East & Africa Intrauterine Devices Market Outlook, By Hormonal IUDs (2022-2030) ($MN)
99 Middle East & Africa Intrauterine Devices Market Outlook, By Non-Hormonal IUDs (2022-2030) ($MN)
100 Middle East & Africa Intrauterine Devices Market Outlook, By Other Types (2022-2030) ($MN)
101 Middle East & Africa Intrauterine Devices Market Outlook, By Material (2022-2030) ($MN)
102 Middle East & Africa Intrauterine Devices Market Outlook, By Levonorgestrel (2022-2030) ($MN)
103 Middle East & Africa Intrauterine Devices Market Outlook, By Copper (2022-2030) ($MN)
104 Middle East & Africa Intrauterine Devices Market Outlook, By Other Materials (2022-2030) ($MN)
105 Middle East & Africa Intrauterine Devices Market Outlook, By Age Group (2022-2030) ($MN)
106 Middle East & Africa Intrauterine Devices Market Outlook, By Teenagers (2022-2030) ($MN)
107 Middle East & Africa Intrauterine Devices Market Outlook, By Adult Women (2022-2030) ($MN)
108 Middle East & Africa Intrauterine Devices Market Outlook, By Other Age Groups (2022-2030) ($MN)
109 Middle East & Africa Intrauterine Devices Market Outlook, By End User (2022-2030) ($MN)
110 Middle East & Africa Intrauterine Devices Market Outlook, By Hospitals (2022-2030) ($MN)
111 Middle East & Africa Intrauterine Devices Market Outlook, By Gynecology Clinics (2022-2030) ($MN)
112 Middle East & Africa Intrauterine Devices Market Outlook, By Community Healthcare Centers (2022-2030) ($MN)
113 Middle East & Africa Intrauterine Devices Market Outlook, By Home Care Settings (2022-2030) ($MN)
114 Middle East & Africa Intrauterine Devices Market Outlook, By Other End Users (2022-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
